Operating
Change in Other Assets
Pfizer Change in Other Assets remained flat by 0.0% to -$322.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 61.9%, from -$845.00M to -$322.25M. Over 4 years (FY 2021 to FY 2025), Change in Other Assets shows a downward trend with a 5.1% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025Feb 26, 2026
How to read this metric
Large fluctuations may indicate changes in corporate strategy, such as significant prepayments for future services or shifts in deferred tax assets.
Detailed definition
This captures the net change in miscellaneous assets that do not fall under standard working capital categories like rec...
Peer comparison
Varies widely based on accounting practices and business complexity.
Metric ID:
change_in_other_assetsHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $1.06B | $4.51B | $663.00M | -$3.38B | -$1.29B |
| YoY Change | — | +326.3% | -85.3% | -609.8% | +61.9% |
Range-$3.38B – $4.51B
CAGR+5.1%
Avg YoY Growth-76.7%
Median YoY Growth-11.7%
Change in Other Assets at Other Companies
Frequently Asked Questions
- What is Pfizer's change in other assets?
- Pfizer (PFE) reported change in other assets of -$322.25M in Q4 2025.
- How has Pfizer's change in other assets changed year-over-year?
- Pfizer's change in other assets increased by 61.9% year-over-year, from -$845.00M to -$322.25M.
- What is the long-term trend for Pfizer's change in other assets?
- Over 4 years (2021 to 2025), Pfizer's change in other assets has grown at a 5.1% compound annual growth rate (CAGR), from $1.06B to -$1.29B.
- What does change in other assets mean?
- The change in miscellaneous short-term assets not classified as inventory or receivables.